When your body suddenly releases a burst of adrenaline—like during a scare or shock—it can make autoimmune thyroid problems worse, even if you don't feel stressed at all.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Adrenaline Surge Events and Autoimmune Thyroid Flares in Humans
Population: Adults with diagnosed autoimmune thyroid disease; Intervention: Documented acute adrenaline surges (e.g., via plasma epinephrine spikes during controlled stressors or panic attacks); Comparator: Periods without adrenaline surges in same individuals; Outcome: Occurrence and severity of thyroid flares (e.g., TSH, TPOAb, clinical symptoms); Duration: Longitudinal tracking over 1–5 years.
Double-Blind Placebo-Controlled Trial of Intravenous Epinephrine Infusion on Thyroid Flare Frequency in Autoimmune Thyroiditis
Population: Adults with stable autoimmune thyroid disease; Intervention: IV epinephrine infusion to mimic acute surge; Comparator: Saline placebo infusion; Outcome: Change in thyroid autoantibody levels, TSH, and clinical flare symptoms within 72 hours; Duration: Single-session crossover design with washout period; Blinding: Double-blind, randomized, crossover.
Prospective Cohort Study of Adrenaline Surges and Autoimmune Thyroid Flares in Patients with Hashimoto’s Thyroiditis
Population: 500 adults with Hashimoto’s thyroiditis; Intervention: Continuous monitoring of epinephrine levels (saliva/blood) and stress perception via daily diaries; Comparator: Participants with and without documented adrenaline surges; Outcome: Frequency and severity of thyroid flares over 2 years; Duration: 24-month prospective follow-up.
Case-Control Study Comparing Recent Adrenaline Surge Exposure in Patients with Recent Thyroid Flares vs. Stable Controls
Population: 200 cases (recent thyroid flare confirmed by labs/symptoms) vs. 200 controls (stable thyroid disease); Intervention: Retrospective assessment of adrenaline surges via medical records, wearable data, or patient recall within 72h of flare onset; Comparator: Controls matched for age, sex, disease duration; Outcome: Odds ratio of surge exposure in cases vs. controls.
In Vitro Effects of Epinephrine on Thyroid Follicular Cell Immune Activation and Autoantigen Expression
Population: Human thyroid follicular cells and peripheral blood mononuclear cells from autoimmune thyroid patients; Intervention: Exposure to physiological and supraphysiological epinephrine concentrations; Comparator: Untreated or isoproterenol-blocked controls; Outcome: Changes in cytokine secretion, autoantigen expression, and T-cell activation markers; Duration: 24–72 hour exposure.
